IndraLab

Statements

Imiquimod inhibits RIPK1. 1 / 1

| 1

reach

"Addition of GM-CSF and imiquimod, however, resulted in dominance of the pan HLA-DR-binding epitope specific response over the OVA specific CD4 T cell responses, decreased OVA specific CD8 T cell numbers and function in tolerant RIP OVA (LOW) mice, and failure to induce diabetes."

20861346

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

Imiquimod inhibits RIPK1. 1 / 1

INDRA sources:

Databases

Reading